Last update Dec. 2, 2022
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Augmentation Mammoplasty is also known as
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Although in some published series no breastfeeding problems have been found (Jewell 2019), after breast augmentation surgery with silicone or saline implants there is an increased risk of insufficient breastfeeding (Marcacine 2018), so the incidence of exclusive breastfeeding is lower (Cheng 2018, Schiff 2014, Andrade 2010, Zuckerman 2010), which implies having competent support for breastfeeding mothers with breast implants. (Roberts 2015)
The factors involved are multiple:
Rare complications are galactorrhea, which is usually transient and treatable, galactoceles, rotation of the prosthesis, seroma, and excessive postpartum inflammation. (Zolotykh 2019, Basile 2015, Irkoren 2013, Meggiorini 2013, Yang 2012, Ayestaray 2012, Tung 2011, Chun 2009)
Most breast implants contain silicone, which is a polymer of silicon-oxygen-methyl atoms of high molecular weight, which makes it practically impossible for the infant to pass into milk in significant quantities as well as subsequent intestinal absorption. This makes them safe for breastfeeding even in case of breakage or manufacturing defects (Poly Implant Prothèse, PIP). After exhaustive analysis of the silicone of these prostheses, a lack of risk to health was demonstrated. (SCENIHR 2013)
The blood and milk silicone levels of women with implants, 55 ng/ml, are similar to those of women without implants, 51 ng/ml, 13 times lower than those found in cows’ milk, 709 ng/ml, and 80 times lower than those of commercial infant formulas, 4403 ng/ml. (Semple 2007 and 1998)
There is no evidence of toxic effects on the infant secondary to the mother wearing a breast, saline or silicone implant. (Preevid 2010)
Polyacrylamide hydrogel injections that have been used to increase breast volume in some countries are inadvisable because they present too many complications in and out of breastfeeding. (Bourke 2018, Wang 2012, Kang 2011, Cheng 2011).
See below the information of this related product: